These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32312820)

  • 41. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease.
    Orieux G; Francois C; Féger J; Yelnik J; Vila M; Ruberg M; Agid Y; Hirsch EC
    Neuroscience; 2000; 97(1):79-88. PubMed ID: 10771341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism.
    Benazzouz A; Tai CH; Meissner W; Bioulac B; Bezard E; Gross C
    FASEB J; 2004 Mar; 18(3):528-30. PubMed ID: 14715698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease.
    Nakao N; Ogura M; Nakai K; Itakura T
    J Neurosci; 1998 Mar; 18(5):1806-17. PubMed ID: 9465005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.
    Wichmann T; Bergman H; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):521-30. PubMed ID: 7983516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of subthalamic deep brain stimulation with duloxetine on mechanical and thermal thresholds in 6OHDA lesioned rats.
    Kaszuba BC; Walling I; Gee LE; Shin DS; Pilitsis JG
    Brain Res; 2017 Jan; 1655():233-241. PubMed ID: 27984022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neuronal activities in the ventrolateral thalamus and basal ganglia in relation to Parkinson's disease].
    Wang J; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1021-6. PubMed ID: 16784702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
    Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
    Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons.
    Mamad O; Delaville C; Benjelloun W; Benazzouz A
    PLoS One; 2015; 10(3):e0119152. PubMed ID: 25742005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus.
    Krause M; Fogel W; Heck A; Hacke W; Bonsanto M; Trenkwalder C; Tronnier V
    J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):464-70. PubMed ID: 11254768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Effects of Mechanical and Thermal Stimuli on Local Field Potentials and Single Unit Activity in Parkinson's Disease Patients.
    Belasen A; Youn Y; Gee L; Prusik J; Lai B; Ramirez-Zamora A; Rizvi K; Yeung P; Shin DS; Argoff C; Pilitsis JG
    Neuromodulation; 2016 Oct; 19(7):698-707. PubMed ID: 27284636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-frequency electrical stimulation of the subthalamic nucleus excites target structures in a model using c-fos immunohistochemistry.
    Shehab S; D'souza C; Ljubisavljevic M; Redgrave P
    Neuroscience; 2014 Jun; 270():212-25. PubMed ID: 24755486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate.
    Moran A; Stein E; Tischler H; Bar-Gad I
    Neurobiol Dis; 2012 Jan; 45(1):583-90. PubMed ID: 22001603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.
    Wichmann T; DeLong MR
    Ann N Y Acad Sci; 2003 Jun; 991():199-213. PubMed ID: 12846988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous and evoked activity of substantia nigra pars reticulata neurons during high-frequency stimulation of the subthalamic nucleus.
    Maurice N; Thierry AM; Glowinski J; Deniau JM
    J Neurosci; 2003 Oct; 23(30):9929-36. PubMed ID: 14586023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.
    Petri D; Pum M; Vesper J; Huston JP; Schnitzler A
    Behav Brain Res; 2013 Sep; 252():58-67. PubMed ID: 23727148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The subthalamic nucleus in the context of movement disorders.
    Hamani C; Saint-Cyr JA; Fraser J; Kaplitt M; Lozano AM
    Brain; 2004 Jan; 127(Pt 1):4-20. PubMed ID: 14607789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.